FDA Details Surveillance Inspections during COVID-19
During COVID-19, the U.S. FDA will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections, FDA Commissioner Stephen Hahn, MD, said in a statement.
Read More